BridgeBio Pharma, Inc. (BBIO)
66.77
-0.96
(-1.42%)
USD |
NASDAQ |
May 27, 15:45
BridgeBio Pharma Free Cash Flow : -452.02M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Pfizer Inc. | 9.484B |
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| Ionis Pharmaceuticals, Inc. | -977.73M |
| BioMarin Pharmaceutical, Inc. | 759.12M |
| Cytokinetics, Inc. | -548.92M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -197.28M |
| Cash from Investing (Quarterly) | -42.74M |
| Cash from Financing (Quarterly) | 549.89M |
| Free Cash Flow Per Share (Quarterly) | -1.013 |
| Free Cash Flow to Equity (Quarterly) | -853.51M |
| Free Cash Flow to Firm (Quarterly) | -144.53M |
| Free Cash Flow Yield | -3.51% |